Vimarsana
Biggest News Aggregation in the World

Christopher Anzalone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christopher Anzalone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christopher Anzalone Today - Breaking & Trending Today

Somalia : US Intelligence Uncovers Possible Houthi-Al-Shabaab Arms Deal - Vimarsana News

Somalia : US Intelligence Uncovers Possible Houthi-Al-Shabaab Arms Deal

Somalia : US Intelligence Uncovers Possible Houthi-Al-Shabaab Arms Deal

Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars - Vimarsana News

Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars

Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference based medicines that utilize the...

Arrowhead Pharmaceuticals Inc CEO Christopher Anzalone Sells 9,952 Shares - Vimarsana News

Arrowhead Pharmaceuticals Inc CEO Christopher Anzalone Sells 9,952 Shares

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CEO, Christopher Anzalone, sold 9,952 shares of the company on January 2, 2024, according to a recent SEC Filing.

Source: yahoo.com
Great week for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional investors after losing 17% over the previous year - Vimarsana News

Great week for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional investors after losing 17% over the previous year

Key Insights Institutions' substantial holdings in Arrowhead Pharmaceuticals implies that they have significant...

Source: yahoo.com
Insider Sell: CEO Christopher Anzalone Sells 24,338 Shares of Arrowhead Pharmaceuticals Inc - Vimarsana News

Insider Sell: CEO Christopher Anzalone Sells 24,338 Shares of Arrowhead Pharmaceuticals Inc

On October 25, 2023, Christopher Anzalone, CEO of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 24,338 shares of the company.

Source: yahoo.com